Brief: Egetis Therapeutics Carries Out Directed Share Issuances Worth SEK 300 Mln

Egetis Therapeutics AB (publ)

01/10/2024 07:40

Oct 1 (Reuters) - Egetis Therapeutics AB  EGTX.ST :
    * SAID ON MONDAY HAS RESOLVED ON DIRECTED SHARE ISSUANCES OF
IN
TOTAL 66,666,667 NEW ORDINARY SHARES
    * SUBSCRIPTION PRICE OF SEK 4.50 PER SHARE
    * ISSUE WAS OVERSUBSCRIBED AND INCLUDED BOTH EXISTING AND
NEW
INTERNATIONAL AND SWEDISH INSTITUTIONAL INVESTORS
    * GETS SEK 300 MLN BEFORE TRANSACTION COSTS

        
 Source text for Workspace:  urn:newsml:reuters.com:*:nMFNZLJGj
 Further company coverage:  EGTX.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))